Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David A. Fischer
CSACI Position Statement: Newer Generation H1-Antihistamines Are Safer Than First-Generation H1-Antihistamines and Should Be the First-Line Antihistamines for the Treatment of Allergic Rhinitis and Urticaria
Allergy, Asthma and Clinical Immunology
Immunology
Pulmonary
Allergy
Respiratory Medicine
Related publications
Antihistamines in Allergic Rhinitis - A Comparative Analysis
Medical Journal Armed Forces India
Medicine
Prophylactic Antihistamines
BMJ
Comparative Trial of Two Non-Sedative H1 Antihistamines, Terfenadine and Astemizole, for Hay Fever.
Thorax
Pulmonary
Respiratory Medicine
Chloropyramine and Ranitidine as a Combination of H1 and H2- Antihistamines in the Additive Therapy of Anaphylaxis
Acta Medica Saliniana
Medicine
Antihistamines for the Common Cold
Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Efficacy and Safety of Omalizumab in Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Efficacy and Safety of Methotrexate Add-On Therapy Versus Placebo for Patients With Chronic Spontaneous Urticaria Resistant to H1-Antihistamines: A Randomized, Controlled Trial
Journal of the American Academy of Dermatology
Dermatology
Antihistamines and Vascular Reactivity
American Journal of Physiology-Legacy Content
